相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Differential impact of the ERBB receptors EGFR and ERBB2 on the initiation of precursor lesions of pancreatic ductal adenocarcinoma
Nora Meyers et al.
SCIENTIFIC REPORTS (2020)
Truncated O-glycans promote epithelial-to-mesenchymal transition and stemness properties of pancreatic cancer cells
Divya Thomas et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)
Inhibition of human mesenchymal stem cell proliferation via Wnt signaling activation
Jung-Sun Moon et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2018)
Cell membrane-anchored MUC4 promotes tumorigenicity in epithelial carcinomas
Pengpeng Xia et al.
ONCOTARGET (2017)
Drug resistance in pancreatic cancer: Impact of altered energy metabolism
Cristoforo Grasso et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2017)
Defective Intestinal Mucin-Type O-Glycosylation Causes Spontaneous Colitis-Associated Cancer in Mice
Kirk Bergstrom et al.
GASTROENTEROLOGY (2016)
The oncogenic receptor ErbB2 modulates gemcitabine and irinotecan/SN-38 chemoresistance of human pancreatic cancer cells via hCNT1 transporter and multidrug-resistance associated protein MRP-2
Nicolas Skrypek et al.
ONCOTARGET (2015)
Up-regulation of C1GALT1 promotes breast cancer cell growth through MUC1-C signaling pathway
Chih-Hsing Chou et al.
ONCOTARGET (2015)
miR-219-1-3p is a negative regulator of the mucin MUC4 expression and is a tumor suppressor in pancreatic cancer
F. Lahdaoui et al.
ONCOGENE (2015)
Glycosylation in cancer: mechanisms and clinical implications
Salome S. Pinho et al.
NATURE REVIEWS CANCER (2015)
Pancreatic Adenocarcinoma
David P. Ryan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Immature truncated O-glycophenotype of cancer directly induces oncogenic features
Prakash Radhakrishnan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
C1GALT1 Enhances Proliferation of Hepatocellular Carcinoma Cells via Modulating MET Glycosylation and Dimerization
Yao-Ming Wu et al.
CANCER RESEARCH (2013)
Aberrant Expression of Mucin Core Proteins and O-Linked Glycans Associated with Progression of Pancreatic Cancer
Neeley Remmers et al.
CLINICAL CANCER RESEARCH (2013)
Precision mapping of the human O-GalNAc glycoproteome through SimpleCell technology
Catharina Steentoft et al.
EMBO JOURNAL (2013)
Expression of core 3 synthase in human pancreatic cancer cells suppresses tumor growth and metastasis
Prakash Radhakrishnan et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
The MUC4 mucin mediates gemcitabine resistance of human pancreatic cancer cells via the Concentrative Nucleoside Transporter family
N. Skrypek et al.
ONCOGENE (2013)
Gemcitabine-mediated tumour regression and p53-dependent gene expression: implications for colon and pancreatic cancer therapy
R. Hill et al.
CELL DEATH & DISEASE (2013)
MUC4 potentiates invasion and metastasis of pancreatic cancer cells through stabilization of fibroblast growth factor receptor 1
Satyanarayana Rachagani et al.
CARCINOGENESIS (2012)
MUC1 in human and murine mammary carcinoma cells decreases the expression of core 2 β1,6-N-acetylglucosaminyltransferase and β-galactoside α2,3-sialyltransferase
Alicja Solatycka et al.
GLYCOBIOLOGY (2012)
Role of MUC4-NIDO domain in the MUC4-mediated metastasis of pancreatic cancer cells
S. Senapati et al.
ONCOGENE (2012)
The Mucin MUC4 and Its Membrane Partner ErbB2 Regulate Biological Properties of Human CAPAN-2 Pancreatic Cancer Cells via Different Signalling Pathways
Nicolas Jonckheere et al.
PLOS ONE (2012)
Sialyl-Tn in Cancer: (How) Did We Miss the Target?
Sylvain Julien et al.
BIOMOLECULES (2012)
The increase in the expression and hypomethylation of MUC4 gene with the progression of pancreatic ductal adenocarcinoma
Yi Zhu et al.
MEDICAL ONCOLOGY (2011)
Progressive Activation of CyclinB1-Cdk1 Coordinates Entry to Mitosis
Olivier Gavet et al.
DEVELOPMENTAL CELL (2010)
Pancreatic cancer cells resistance to gemcitabine: the role of MUC4 mucin
S. Bafna et al.
BRITISH JOURNAL OF CANCER (2009)
The Membrane Mucin Muc4 Inhibits Apoptosis Induced by Multiple Insults via ErbB2-Dependent and ErbB2-Independent Mechanisms
Heather C. Workman et al.
CANCER RESEARCH (2009)
Mucin overexpression limits the effectiveness of 5-FU by reducing intracellular drug uptake and antineoplastic drug effects in pancreatic tumours
Ashish V. Kalra et al.
EUROPEAN JOURNAL OF CANCER (2009)
Muc4/MUC4 functions and regulation in cancer
Kermit L. Carraway et al.
FUTURE ONCOLOGY (2009)
MUC4 mucin interacts with and stabilizes the HER2 oncoprotein in human pancreatic cancer cells
Pallavi Chaturvedi et al.
CANCER RESEARCH (2008)
The mucin muc4 potentiates neuregulin signaling by increasing the cell-surface populations of ErbB2 and ErbB3
Melanie Funes et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Muc4-ErbB2 complex formation and signaling in polarized CACO-2 epithelial cells indicate that Muc4 acts as an unorthodox ligand for ErbB2
Victoria P. Ramsauer et al.
MOLECULAR BIOLOGY OF THE CELL (2006)
MUC4 expression and its relation to ErbB2 expression, apoptosis, proliferation, differentiation, and tumor stage in non-small cell lung cancer (NSCLC)
Aydanur Kargi et al.
PATHOLOGY RESEARCH AND PRACTICE (2006)
MUC4 expression is a novel prognostic factor in patients with invasive ductal carcinoma of the pancreas
M Saitou et al.
JOURNAL OF CLINICAL PATHOLOGY (2005)
Inhibition of MUC4 expression suppresses pancreatic tumor cell growth and metastasis
AP Singh et al.
CANCER RESEARCH (2004)
Mucins in cancer: Protection and control of the cell surface
MA Hollingsworth et al.
NATURE REVIEWS CANCER (2004)
Nucleoside anticancer drugs: the role of nucleoside transporters in resistance to cancer chemotherapy
VL Damaraju et al.
ONCOGENE (2003)
Muc4/sialomucin complex, an intramembrane modulator of ErbB2/HER2/Neu, potentiates primary tumor growth and suppresses apoptosis in a xenotransplanted tumor
M Komatsu et al.
ONCOGENE (2001)
分享论文
